For baclofen long-term therapy, which is an important consideration?

For baclofen long-term therapy, which is an important consideration?

• A. Prepare the client for an implantable baclofen pump device.
• B. Monitor for constipation as a common side effect.
• C. Prepare to administer a test dose as ordered by the healthcare provider.
• D. Immediately discontinue if mild dizziness occurs.

Answer: (C)

The main idea here is to gauge how well and safely baclofen will work for a patient before committing to long-term or intrathecal therapy. A test dose provides real-time insight into both effectiveness in reducing spasticity and potential side effects, guiding the dosing plan and whether proceeding with an implanted baclofen pump is appropriate. By observing the patient in a monitored setting after a small, controlled dose, clinicians can tailor the treatment and anticipate any tolerability issues. While an implantable pump may be considered later, it isn’t assumed to be the next step for everyone. Constipation isn’t the defining concern, dizziness is a possible side effect but doesn’t justify stopping therapy, and stopping abruptly for mild dizziness isn’t appropriate.

The main idea here is to gauge how well and safely baclofen will work for a patient before committing to long-term or intrathecal therapy. A test dose provides real-time insight into both effectiveness in reducing spasticity and potential side effects, guiding the dosing plan and whether proceeding with an implanted baclofen pump is appropriate. By observing the patient in a monitored setting after a small, controlled dose, clinicians can tailor the treatment and anticipate any tolerability issues. While an implantable pump may be considered later, it isn’t assumed to be the next step for everyone. Constipation isn’t the defining concern, dizziness is a possible side effect but doesn’t justify stopping therapy, and stopping abruptly for mild dizziness isn’t appropriate.